Angela is a Master Student at the University of Zürich. Her interest is in understanding how absolute enzyme levels in primary tumors drive the metabolic reprogramming in pediatric cancers. She is currently investigating genetic approaches to finetune expression levels in model systems to match primary data. Besides a special focus on genetics she is involved in metabolic phenotyping using metabolomics and drug response profiling. The goal of her project is to identify patient specific vulnerability for targeting folate metabolism.